Analysts at HC Wainwright upped their price objective on shares of Insmed Incorporated (NASDAQ:INSM) from $25.00 to $30.00 in a research report issued to clients and investors on Wednesday, Stock Ratings Network.com reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 63.93% from the stock’s previous close. Insmed Incorporated (NASDAQ:INSM) shares after opening at $12.49on last trade day and at the end of the day closed at $13.41. Company price to sales ratio in past twelve months was calculated as 45.79 and price to cash ratio as 4.62. Insmed Incorporated (NASDAQ:INSM)showed a negative weekly performance of -14.04%.
NQ Mobile Inc (ADR) (NYSE:NQ) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. NQ Mobile Inc (ADR) (NYSE:NQ)shares advanced 5.22% in last trading session and ended the day on $12.90.NQ return on equity ratio is recorded as 2.80% and its return on assets is 2.40%. NQ Mobile Inc (ADR) (NYSE:NQ) yearly performance is 59.85%.
TherapeuticsMD (NASDAQ:TXMD) had its target price lifted by Noble Financial from $9.00 to $13.00 in a research note released on Thursday morning, StockRatingsNetwork reports. They currently have a buy rating on the stock.TherapeuticsMD Inc (NYSEMKT:TXMD) weekly performance is 4.26%. On last trading day company shares ended up $4.90.TherapeuticsMD Inc (NYSEMKT:TXMD)distance from 50-day simple moving average (SMA50) is 757%. Analysts mean target price for the company is $8.75.
Avanir Pharmaceuticals Inc (NASDAQ:AVNR)shares moved up 1.55% in last trading session and was closed at $3.46, while trading in range of $3.34 -$3.63. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) year to date (YTD) performance is16.89%.